Diabetic Microvascular Disease and Pulmonary Fibrosis: The Contribution of Platelets and Systemic Inflammation
Diabetes is strongly associated with systemic inflammation and oxidative stress, but its effect on pulmonary vascular disease and lung function has often been disregarded. Several studies identified restrictive lung disease and fibrotic changes in diabetic patients and in animal models of diabetes....
Main Authors: | Rekha Jagadapillai, Madhavi J. Rane, Xingyu Lin, Andrew M. Roberts, Gary W. Hoyle, Lu Cai, Evelyne Gozal |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | http://www.mdpi.com/1422-0067/17/11/1853 |
Similar Items
-
Janus kinase inhibitors ruxolitinib and baricitinib impair glycoprotein-VI mediated platelet function
by: Iván Parra-Izquierdo, et al.
Published: (2022-04-01) -
The Controversial Role of Fibrosis in Autosomal Dominant Polycystic Kidney Disease
by: Maria Fragiadaki, et al.
Published: (2020-11-01) -
Lysozyme promotes renal fibrosis through the JAK/STAT3 signal pathway in diabetic nephropathy
by: Yan Ren, et al.
Published: (2023-07-01) -
Pirfenidone ameliorates pulmonary inflammation and fibrosis in a rat silicosis model by inhibiting macrophage polarization and JAK2/STAT3 signaling pathways
by: Qiong Tang, et al.
Published: (2022-10-01) -
Baricitinib Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice by Inhibiting TGF-β1 Signaling Pathway
by: Songtao Gu, et al.
Published: (2023-02-01)